Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Food, Fortified | 8 | 2020 | 191 | 2.390 |
Why?
|
Folic Acid | 8 | 2024 | 1300 | 2.160 |
Why?
|
Dietary Supplements | 12 | 2024 | 3297 | 1.530 |
Why?
|
Poland | 12 | 2020 | 184 | 1.040 |
Why?
|
Micronutrients | 3 | 2019 | 375 | 1.030 |
Why?
|
Diet, Mediterranean | 4 | 2023 | 700 | 0.910 |
Why?
|
Nutritional Requirements | 5 | 2013 | 286 | 0.900 |
Why?
|
Food Analysis | 2 | 2013 | 104 | 0.820 |
Why?
|
Gastrointestinal Stromal Tumors | 7 | 2022 | 643 | 0.800 |
Why?
|
Folic Acid Deficiency | 3 | 2011 | 115 | 0.780 |
Why?
|
Leiomyosarcoma | 2 | 2022 | 477 | 0.750 |
Why?
|
Nutritional Status | 10 | 2024 | 1609 | 0.750 |
Why?
|
Vitamins | 4 | 2020 | 1622 | 0.720 |
Why?
|
Cyclins | 7 | 2018 | 603 | 0.680 |
Why?
|
Tetrahydrofolates | 1 | 2017 | 61 | 0.580 |
Why?
|
Gastrointestinal Neoplasms | 5 | 2022 | 990 | 0.510 |
Why?
|
Nutritive Value | 3 | 2013 | 339 | 0.500 |
Why?
|
Students | 4 | 2024 | 1654 | 0.490 |
Why?
|
Diet | 8 | 2023 | 7939 | 0.480 |
Why?
|
Homocysteine | 1 | 2017 | 647 | 0.470 |
Why?
|
Vitamin B Complex | 2 | 2017 | 288 | 0.450 |
Why?
|
Cyclin D3 | 7 | 2017 | 55 | 0.440 |
Why?
|
Cyclin-Dependent Kinase 4 | 6 | 2022 | 538 | 0.430 |
Why?
|
Proto-Oncogene Proteins c-kit | 7 | 2022 | 776 | 0.400 |
Why?
|
Malnutrition | 3 | 2013 | 625 | 0.400 |
Why?
|
Cyclin-Dependent Kinase 6 | 4 | 2022 | 322 | 0.390 |
Why?
|
Cell Cycle | 12 | 2017 | 2967 | 0.390 |
Why?
|
Life Style | 2 | 2022 | 3835 | 0.390 |
Why?
|
Educational Status | 1 | 2019 | 2540 | 0.380 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2012 | 116 | 0.380 |
Why?
|
Social Class | 2 | 2019 | 1999 | 0.370 |
Why?
|
Minerals | 3 | 2020 | 275 | 0.350 |
Why?
|
Health Status | 2 | 2019 | 4034 | 0.350 |
Why?
|
Liposarcoma | 4 | 2014 | 333 | 0.350 |
Why?
|
Colorectal Neoplasms | 7 | 2024 | 6773 | 0.340 |
Why?
|
Vitamin B 12 | 1 | 2012 | 527 | 0.330 |
Why?
|
Universities | 2 | 2024 | 956 | 0.300 |
Why?
|
Cell Line, Tumor | 25 | 2023 | 16689 | 0.300 |
Why?
|
Health Behavior | 1 | 2019 | 2636 | 0.290 |
Why?
|
Food Supply | 1 | 2013 | 524 | 0.290 |
Why?
|
Nutrition Policy | 4 | 2016 | 488 | 0.290 |
Why?
|
Pancreatic Neoplasms | 5 | 2023 | 5256 | 0.290 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2023 | 1634 | 0.270 |
Why?
|
Xenograft Model Antitumor Assays | 10 | 2020 | 3557 | 0.270 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2020 | 705 | 0.270 |
Why?
|
Neuroendocrine Tumors | 2 | 2023 | 594 | 0.260 |
Why?
|
Cell Proliferation | 9 | 2019 | 10481 | 0.260 |
Why?
|
Attitude to Health | 2 | 2012 | 2052 | 0.250 |
Why?
|
Leukemia, T-Cell | 1 | 2003 | 104 | 0.230 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2022 | 1660 | 0.230 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2006 | 648 | 0.230 |
Why?
|
Cyclin D1 | 5 | 2006 | 463 | 0.230 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3586 | 0.220 |
Why?
|
Cyclin E | 3 | 2018 | 172 | 0.220 |
Why?
|
Fusobacterium nucleatum | 1 | 2024 | 162 | 0.220 |
Why?
|
Stomach Neoplasms | 2 | 2023 | 1333 | 0.210 |
Why?
|
Succinate Dehydrogenase | 2 | 2019 | 146 | 0.200 |
Why?
|
Apoptosis | 7 | 2023 | 9727 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2014 | 286 | 0.200 |
Why?
|
Intestinal Neoplasms | 1 | 2023 | 319 | 0.190 |
Why?
|
Protein Kinase Inhibitors | 5 | 2021 | 5535 | 0.190 |
Why?
|
Histone Acetyltransferases | 1 | 2022 | 336 | 0.180 |
Why?
|
Humans | 68 | 2024 | 744343 | 0.180 |
Why?
|
Mice | 31 | 2024 | 81183 | 0.180 |
Why?
|
Urban Population | 2 | 2011 | 2021 | 0.180 |
Why?
|
Sequence Analysis, RNA | 3 | 2022 | 2012 | 0.170 |
Why?
|
Cell Differentiation | 8 | 2017 | 11483 | 0.170 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2023 | 370 | 0.170 |
Why?
|
Asparaginase | 1 | 2020 | 236 | 0.170 |
Why?
|
Mice, Nude | 8 | 2019 | 3689 | 0.160 |
Why?
|
Esophageal Neoplasms | 3 | 2020 | 1583 | 0.160 |
Why?
|
Neoplasms, Experimental | 2 | 2020 | 1276 | 0.160 |
Why?
|
Fusobacterium | 1 | 2017 | 54 | 0.150 |
Why?
|
Population Surveillance | 2 | 2013 | 2616 | 0.150 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 112 | 0.150 |
Why?
|
Demography | 1 | 2022 | 1656 | 0.150 |
Why?
|
Vitamin A | 1 | 2020 | 615 | 0.150 |
Why?
|
Mouth Neoplasms | 1 | 2022 | 601 | 0.150 |
Why?
|
Animals | 36 | 2024 | 168757 | 0.150 |
Why?
|
Metronidazole | 1 | 2017 | 217 | 0.140 |
Why?
|
Female | 34 | 2024 | 380194 | 0.140 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2022 | 2109 | 0.140 |
Why?
|
Infertility | 1 | 2023 | 655 | 0.140 |
Why?
|
Uterus | 1 | 2020 | 711 | 0.140 |
Why?
|
Enhancer Elements, Genetic | 2 | 2019 | 1341 | 0.130 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2022 | 2938 | 0.130 |
Why?
|
Lymphocytes | 1 | 2003 | 2617 | 0.130 |
Why?
|
Karyopherins | 1 | 2016 | 137 | 0.130 |
Why?
|
Barrett Esophagus | 2 | 2020 | 494 | 0.130 |
Why?
|
Genes, Neoplasm | 1 | 2017 | 376 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2022 | 9438 | 0.130 |
Why?
|
MAP Kinase Signaling System | 3 | 2018 | 1526 | 0.130 |
Why?
|
Dermatofibrosarcoma | 1 | 2015 | 63 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 315 | 0.120 |
Why?
|
Interferons | 1 | 2018 | 706 | 0.120 |
Why?
|
Antigens, Protozoan | 1 | 2017 | 322 | 0.120 |
Why?
|
Hydrazines | 1 | 2016 | 226 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2022 | 4034 | 0.120 |
Why?
|
Gene Expression | 4 | 2022 | 7799 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 8428 | 0.120 |
Why?
|
Triazoles | 2 | 2019 | 911 | 0.120 |
Why?
|
Enzyme Activators | 1 | 2014 | 57 | 0.120 |
Why?
|
Neutrophils | 1 | 2006 | 3719 | 0.120 |
Why?
|
Young Adult | 6 | 2020 | 56430 | 0.120 |
Why?
|
Sarcoma | 2 | 2016 | 1897 | 0.120 |
Why?
|
Oncogenes | 1 | 2019 | 1265 | 0.110 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2014 | 197 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2948 | 0.110 |
Why?
|
Liver Neoplasms | 3 | 2018 | 4253 | 0.110 |
Why?
|
Feeding Behavior | 2 | 2019 | 3188 | 0.110 |
Why?
|
Mice, Knockout | 10 | 2020 | 14557 | 0.110 |
Why?
|
Chromosome Aberrations | 1 | 2019 | 1813 | 0.110 |
Why?
|
Precancerous Conditions | 1 | 2020 | 975 | 0.110 |
Why?
|
Male | 28 | 2022 | 350118 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1581 | 0.110 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1861 | 0.110 |
Why?
|
Policy Making | 2 | 2014 | 554 | 0.110 |
Why?
|
Rural Population | 1 | 2003 | 2210 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 2 | 3 | 2022 | 191 | 0.100 |
Why?
|
Lipogenesis | 1 | 2014 | 212 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18029 | 0.100 |
Why?
|
Cyclin D2 | 4 | 2005 | 101 | 0.100 |
Why?
|
Schools | 1 | 2020 | 1433 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1285 | 0.100 |
Why?
|
Mucous Membrane | 1 | 2015 | 673 | 0.100 |
Why?
|
Transcription Factors | 4 | 2022 | 12208 | 0.100 |
Why?
|
Exercise | 2 | 2019 | 5615 | 0.100 |
Why?
|
Food Preferences | 2 | 2012 | 399 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 871 | 0.100 |
Why?
|
MicroRNAs | 2 | 2017 | 3752 | 0.100 |
Why?
|
Adenocarcinoma | 3 | 2020 | 6364 | 0.100 |
Why?
|
Chondrosarcoma | 1 | 2013 | 309 | 0.090 |
Why?
|
Adult | 11 | 2021 | 214055 | 0.090 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 611 | 0.090 |
Why?
|
Body Mass Index | 2 | 2019 | 12720 | 0.090 |
Why?
|
Mutation | 9 | 2022 | 29786 | 0.090 |
Why?
|
Uncertainty | 1 | 2014 | 734 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2019 | 5172 | 0.090 |
Why?
|
Neural Tube Defects | 1 | 2011 | 256 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2541 | 0.080 |
Why?
|
Quinolines | 1 | 2013 | 732 | 0.080 |
Why?
|
Food Services | 1 | 2011 | 192 | 0.080 |
Why?
|
Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2006 | 21 | 0.070 |
Why?
|
Carbon-Nitrogen Lyases | 1 | 2006 | 8 | 0.070 |
Why?
|
DNA Fragmentation | 1 | 2007 | 242 | 0.070 |
Why?
|
Neoplasms | 4 | 2023 | 21683 | 0.070 |
Why?
|
Imidazoles | 1 | 2013 | 1206 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2017 | 1139 | 0.070 |
Why?
|
Prostatic Neoplasms | 4 | 2014 | 11124 | 0.070 |
Why?
|
Disease Progression | 6 | 2022 | 13284 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 2958 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2013 | 2503 | 0.070 |
Why?
|
Blotting, Western | 5 | 2016 | 5179 | 0.070 |
Why?
|
Enzyme Activation | 4 | 2017 | 3701 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3462 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2017 | 3023 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2018 | 379 | 0.070 |
Why?
|
Phosphorylation | 5 | 2017 | 8436 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7785 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3022 | 0.060 |
Why?
|
RNA, Small Interfering | 4 | 2014 | 3505 | 0.060 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2007 | 323 | 0.060 |
Why?
|
Cell Lineage | 2 | 2019 | 2504 | 0.060 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2023 | 449 | 0.060 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2003 | 91 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9146 | 0.060 |
Why?
|
Pregnancy | 4 | 2016 | 29144 | 0.060 |
Why?
|
Aged | 10 | 2021 | 163280 | 0.060 |
Why?
|
Retinoblastoma Protein | 3 | 2015 | 704 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6103 | 0.060 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2006 | 415 | 0.060 |
Why?
|
Embryo, Mammalian | 3 | 2004 | 1701 | 0.060 |
Why?
|
Blood Pressure | 1 | 2019 | 8554 | 0.060 |
Why?
|
Anemia, Megaloblastic | 1 | 2002 | 25 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2017 | 12026 | 0.060 |
Why?
|
Erythrocytes | 1 | 2012 | 2455 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2006 | 520 | 0.050 |
Why?
|
Endopeptidases | 1 | 2006 | 772 | 0.050 |
Why?
|
Purines | 2 | 2017 | 594 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6544 | 0.050 |
Why?
|
Aminopyridines | 2 | 2017 | 542 | 0.050 |
Why?
|
Adipocytes | 1 | 2009 | 1184 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5720 | 0.050 |
Why?
|
Dysmenorrhea | 1 | 2023 | 86 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5217 | 0.050 |
Why?
|
Single-Cell Analysis | 2 | 2023 | 2183 | 0.050 |
Why?
|
Adolescent | 2 | 2020 | 85781 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2023 | 174 | 0.050 |
Why?
|
Neutropenia | 1 | 2006 | 895 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2013 | 2529 | 0.050 |
Why?
|
Vitamin D | 1 | 2014 | 3223 | 0.050 |
Why?
|
Child | 4 | 2019 | 77709 | 0.050 |
Why?
|
Methylnitrosourea | 1 | 2020 | 29 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 644 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10638 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 648 | 0.050 |
Why?
|
Fibroblast Growth Factor 4 | 1 | 2019 | 27 | 0.050 |
Why?
|
Receptors, Androgen | 1 | 2006 | 1058 | 0.040 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2012 | 303 | 0.040 |
Why?
|
Middle Aged | 8 | 2021 | 213383 | 0.040 |
Why?
|
Public Health | 1 | 2013 | 2603 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1692 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1782 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7181 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2019 | 4204 | 0.040 |
Why?
|
Gene Amplification | 2 | 2017 | 1063 | 0.040 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2019 | 185 | 0.040 |
Why?
|
Receptors, Notch | 1 | 2003 | 739 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8480 | 0.040 |
Why?
|
Esters | 1 | 1999 | 210 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 21827 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2005 | 1352 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 2513 | 0.040 |
Why?
|
Health Promotion | 1 | 2011 | 2205 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9734 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2014 | 2085 | 0.040 |
Why?
|
RNA, Antisense | 1 | 2018 | 138 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 25043 | 0.040 |
Why?
|
Bacterial Infections | 1 | 2006 | 1401 | 0.040 |
Why?
|
Prevotella | 1 | 2017 | 79 | 0.040 |
Why?
|
Phosphofructokinase-1 | 1 | 2017 | 51 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2022 | 810 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3647 | 0.040 |
Why?
|
Reactive Nitrogen Species | 1 | 2017 | 35 | 0.040 |
Why?
|
HT29 Cells | 1 | 2017 | 200 | 0.040 |
Why?
|
Child Welfare | 2 | 2012 | 523 | 0.040 |
Why?
|
Bacteroides | 1 | 2017 | 161 | 0.040 |
Why?
|
Pentose Phosphate Pathway | 1 | 2017 | 124 | 0.040 |
Why?
|
Cricetulus | 1 | 2019 | 816 | 0.040 |
Why?
|
Models, Animal | 1 | 2003 | 2171 | 0.040 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2018 | 191 | 0.040 |
Why?
|
Cell Line | 3 | 2019 | 15997 | 0.040 |
Why?
|
Fallopian Tubes | 1 | 2017 | 182 | 0.040 |
Why?
|
raf Kinases | 1 | 2017 | 122 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 2 | 2006 | 3386 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2018 | 57776 | 0.040 |
Why?
|
Azepines | 1 | 2019 | 336 | 0.040 |
Why?
|
Systole | 1 | 2019 | 958 | 0.040 |
Why?
|
Cell Survival | 2 | 2017 | 5882 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2004 | 5974 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 299 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2006 | 2416 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2019 | 629 | 0.030 |
Why?
|
CHO Cells | 1 | 2019 | 1406 | 0.030 |
Why?
|
Gene Silencing | 2 | 2017 | 1538 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2727 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2017 | 408 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11366 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 528 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6314 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2017 | 196 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4851 | 0.030 |
Why?
|
Pyruvate Kinase | 1 | 2017 | 189 | 0.030 |
Why?
|
Cerebellum | 1 | 2002 | 1488 | 0.030 |
Why?
|
Longevity | 1 | 2023 | 1070 | 0.030 |
Why?
|
Pyridines | 2 | 2019 | 2825 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 513 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3920 | 0.030 |
Why?
|
Intestines | 1 | 2024 | 1924 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2017 | 371 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2017 | 1827 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2015 | 251 | 0.030 |
Why?
|
Respiratory Mucosa | 1 | 2017 | 427 | 0.030 |
Why?
|
Genome, Human | 1 | 2007 | 4420 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13695 | 0.030 |
Why?
|
New Zealand | 1 | 2014 | 355 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 701 | 0.030 |
Why?
|
Cilia | 1 | 2017 | 466 | 0.030 |
Why?
|
Cell Dedifferentiation | 1 | 2014 | 135 | 0.030 |
Why?
|
Oncogene Proteins | 1 | 2018 | 749 | 0.030 |
Why?
|
Serine | 1 | 2017 | 826 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 730 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2010 | 2649 | 0.030 |
Why?
|
Bone Marrow | 1 | 2003 | 2948 | 0.030 |
Why?
|
Spain | 1 | 2014 | 465 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 910 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2015 | 389 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 827 | 0.030 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 407 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2004 | 3617 | 0.030 |
Why?
|
Signal Transduction | 3 | 2016 | 23403 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2006 | 4665 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2013 | 459 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2013 | 7880 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1114 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2017 | 1401 | 0.030 |
Why?
|
Pyridones | 1 | 2017 | 712 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2002 | 1622 | 0.030 |
Why?
|
Gene Fusion | 1 | 2015 | 371 | 0.030 |
Why?
|
Collagen Type I | 1 | 2015 | 592 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 713 | 0.030 |
Why?
|
Fatty Acids | 1 | 1999 | 1809 | 0.030 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3610 | 0.030 |
Why?
|
Interleukin-4 | 1 | 2015 | 1147 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 553 | 0.020 |
Why?
|
Australia | 1 | 2014 | 1170 | 0.020 |
Why?
|
K562 Cells | 1 | 2012 | 634 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2013 | 479 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2934 | 0.020 |
Why?
|
Cell Size | 1 | 2012 | 643 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1788 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2013 | 509 | 0.020 |
Why?
|
Netherlands | 1 | 2014 | 2170 | 0.020 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2009 | 22 | 0.020 |
Why?
|
Genes, jun | 1 | 2009 | 71 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2421 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1252 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2077 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1708 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.020 |
Why?
|
Trans-Activators | 1 | 2019 | 2924 | 0.020 |
Why?
|
Genes, p53 | 1 | 2011 | 755 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2046 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4751 | 0.020 |
Why?
|
Erythropoiesis | 1 | 2012 | 705 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1856 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4186 | 0.020 |
Why?
|
Transfection | 2 | 2006 | 5892 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2013 | 1344 | 0.020 |
Why?
|
Medical Oncology | 1 | 2019 | 2265 | 0.020 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 79 | 0.020 |
Why?
|
Time Factors | 4 | 2019 | 40075 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1655 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6895 | 0.020 |
Why?
|
Temperature | 2 | 2007 | 2206 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 19229 | 0.020 |
Why?
|
Parent-Child Relations | 1 | 2012 | 747 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6171 | 0.020 |
Why?
|
Gene Deletion | 1 | 2015 | 2751 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 1999 | 3966 | 0.020 |
Why?
|
Food | 1 | 2012 | 771 | 0.020 |
Why?
|
Family Characteristics | 1 | 2012 | 1000 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2019 | 4554 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 3913 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2005 | 5751 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 3002 | 0.020 |
Why?
|
Tissue Fixation | 1 | 2007 | 241 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2006 | 356 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2889 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3339 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3086 | 0.020 |
Why?
|
Cell Division | 2 | 2004 | 4568 | 0.020 |
Why?
|
Formaldehyde | 1 | 2007 | 353 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 2006 | 190 | 0.020 |
Why?
|
Qualitative Research | 1 | 2014 | 2682 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2219 | 0.020 |
Why?
|
Androgen Receptor Antagonists | 1 | 2006 | 114 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4286 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 399 | 0.020 |
Why?
|
Nanoparticles | 1 | 2017 | 1905 | 0.020 |
Why?
|
Genes, erbB-2 | 1 | 2006 | 162 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2020 | 4234 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2010 | 1878 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1990 | 0.020 |
Why?
|
Methylcellulose | 1 | 2004 | 37 | 0.020 |
Why?
|
Eating | 1 | 2012 | 1536 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8664 | 0.020 |
Why?
|
Cyclin A | 1 | 2004 | 60 | 0.020 |
Why?
|
Soft Tissue Neoplasms | 1 | 2014 | 1363 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 15519 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2017 | 20822 | 0.020 |
Why?
|
Piperazines | 1 | 2015 | 2488 | 0.020 |
Why?
|
Mice, SCID | 1 | 2010 | 2716 | 0.020 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2004 | 113 | 0.020 |
Why?
|
Phenotype | 2 | 2017 | 16365 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2013 | 2564 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2004 | 2942 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2703 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2006 | 769 | 0.010 |
Why?
|
Body Weight | 1 | 2014 | 4669 | 0.010 |
Why?
|
Hyperhomocysteinemia | 1 | 2004 | 124 | 0.010 |
Why?
|
Glucagon | 1 | 2005 | 533 | 0.010 |
Why?
|
Protein Binding | 2 | 2006 | 9386 | 0.010 |
Why?
|
Cardiovascular Abnormalities | 1 | 2003 | 144 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2004 | 1581 | 0.010 |
Why?
|
Spermatogenesis | 1 | 2003 | 262 | 0.010 |
Why?
|
Trophoblasts | 1 | 2003 | 215 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2002 | 438 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 1758 | 0.010 |
Why?
|
Genes, myc | 1 | 2002 | 399 | 0.010 |
Why?
|
Ubiquitin | 1 | 2006 | 852 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
Glucose Intolerance | 1 | 2005 | 577 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11031 | 0.010 |
Why?
|
Decision Making | 1 | 2014 | 3887 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29063 | 0.010 |
Why?
|
Retroviridae | 1 | 2002 | 914 | 0.010 |
Why?
|
Zebrafish | 1 | 2011 | 2994 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2010 | 2494 | 0.010 |
Why?
|
Gene Targeting | 1 | 2003 | 880 | 0.010 |
Why?
|
Megakaryocytes | 1 | 2003 | 545 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2006 | 13033 | 0.010 |
Why?
|
Blood Preservation | 1 | 1999 | 177 | 0.010 |
Why?
|
Androgens | 1 | 2006 | 1281 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2002 | 1950 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12261 | 0.010 |
Why?
|
Alcoholic Beverages | 1 | 1999 | 265 | 0.010 |
Why?
|
Health Education | 1 | 2004 | 1056 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6622 | 0.010 |
Why?
|
DNA Replication | 1 | 2003 | 1399 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 13881 | 0.010 |
Why?
|
Primary Prevention | 1 | 2004 | 1167 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12797 | 0.010 |
Why?
|
Cryopreservation | 1 | 1999 | 670 | 0.010 |
Why?
|
Placenta | 1 | 2003 | 1698 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 12072 | 0.010 |
Why?
|
Fibroblasts | 1 | 2004 | 4161 | 0.010 |
Why?
|
Triglycerides | 1 | 1999 | 2454 | 0.010 |
Why?
|
Stem Cells | 1 | 2004 | 3567 | 0.010 |
Why?
|
Blood Glucose | 1 | 2005 | 6256 | 0.010 |
Why?
|
Insulin | 1 | 2005 | 6580 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 77449 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2004 | 4043 | 0.010 |
Why?
|
Models, Biological | 1 | 2004 | 9583 | 0.000 |
Why?
|
Sex Factors | 1 | 1999 | 10397 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 15165 | 0.000 |
Why?
|
Risk Factors | 1 | 2004 | 72290 | 0.000 |
Why?
|